MedPath

Evaluation of different complete blood count(CBC) parameters in prognosis of COVID -19 patients

Not yet recruiting
Conditions
Coronavirus as the cause of diseases classified elsewhere,
Registration Number
CTRI/2021/01/030789
Lead Sponsor
KIMS Hospital
Brief Summary

The study aims to assess the role of hematological parameters ,both direct and derived, in predicting the severity of COVID 19 patients.The parameters like absolute lymphocyte count,total leukocyte count,absolute neutrophil count, neutrophil lymphocyte ratio,platelet lymphocyte ratio,RDW to total platelet count ratio,mean platelet volume etc will be evaluated in predicting the severity of disease requiring early intervention in COVID 19 patients.These parameters will be correlated with other biochemical and clinical parameters also.

The results obtained in the study will be published in appropriate journals.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

1)ALL RT-PCR POSITIVE COVID-19 PATIENTS.

Exclusion Criteria
  • 1)All COVID unrelated cases .
  • 2)Patients in which proper clinical details missing.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
These parameters are expected to act as indicators of immune status of patient, hyperinflammatory and cytokine storm status, indicators of superinfection , disease severity and extent of systemic inflammationThe parameters will be assessed at the time of admission and at the time of discharge in case of general ward patients and at 1 week interval in case of ICU patients
Secondary Outcome Measures
NameTimeMethod
FEW DERIVED HEMATOLOGICAL PARAMETERS CAN ACT AS INDICTORS OF POOR PROGNOSIS IN COVID 19 PATIENTSParameters will be assessed at the time of discharge in general ward patients and at 1 week interval in ICU patients

Trial Locations

Locations (1)

ODISHA COVID HOSPITAL,KIMS

🇮🇳

Khordha, ORISSA, India

ODISHA COVID HOSPITAL,KIMS
🇮🇳Khordha, ORISSA, India
DR SAROJINI RAMAN
Principal investigator
7077288117
sarojini.raman@kims.ac.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.